Privileged natural product compound classes for anti-inflammatory drug development
Malcolm Z Y Choo1, Julian A T Chua1, Sean X Y Lee1
1Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, 117543, Singapore. phacllc@nus.edu.sg.
Natural products offer privileged compound classes for anti-inflammatory drug discovery. This review highlights six classes, discussing their potential and challenges for therapeutic development.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Natural Product Chemistry
Background:
- Natural products with anti-inflammatory properties are key starting points for drug discovery.
- Privileged compound classes, including polyphenols, coumarins, and alkaloids, offer diverse scaffolds for targeting inflammation.
- Natural products present both opportunities (multi-targeting) and challenges (promiscuity, pharmacokinetics) in therapeutic development.
Purpose of the Study:
- To review privileged compound classes of natural products with anti-inflammatory properties.
- To discuss the potential and challenges of these natural products as anti-inflammatory drug leads.
- To highlight six specific classes for their relevance in medicinal chemistry and drug discovery.
Main Methods:
- Literature review of natural products with anti-inflammatory activities.
- Identification and categorization of privileged compound classes.
- Analysis of molecular scaffolds, functional groups, and biological target interactions.
- Discussion of medicinal chemistry challenges and therapeutic potential.
Main Results:
- Six privileged compound classes (polyphenols, coumarins, labdane diterpenoids, sesquiterpene lactones, isoquinoline alkaloids, indole alkaloids) possess significant anti-inflammatory potential.
- These classes provide diverse chemical structures amenable to drug design.
- Challenges include multi-targeting, promiscuity, and suboptimal pharmacokinetic profiles.
Conclusions:
- Privileged natural product classes are valuable resources for developing novel anti-inflammatory agents.
- Further medicinal chemistry efforts are needed to optimize potency and pharmacokinetic properties.
- Continued research is essential to overcome controversies and fully realize the therapeutic potential of these compounds.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Related Concept Videos
Drug Classes and Categories
Drugs for Treatment of Ulcerative Colitis in IBD
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Opioid Analgesics: Morphine and Other Natural Cogeners
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
